Improving the Pharmacovigilance System in Medical Organisations as an Opportunity to Enhance the Quality of Pharmacotherapy
INTRODUCTION. It is essential to monitor the efficacy and safety of medicinal products as part of post-marketing surveillance to identify, assess, and prevent adverse drug reactions (ADRs). The effectiveness of pharmacovigilance depends largely on healthcare professionals’ adherence to the requireme...
Zapisane w:
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Russo |
| Wydane: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2025-04-01
|
| Seria: | Безопасность и риск фармакотерапии |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.risksafety.ru/jour/article/view/491 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|